Motilent - Changing the way we see the gut

Entrolytics
GIQuant
Bridge
vEUA

Entrolytics

Entrolytics is Motilent’s secure, end-to-end medical imaging platform optimised for gastrointestinal data. It makes it simple to organise, analyse, and collaborate with all your data in one place.

Purpose-built for digestive disease, Entrolytics combines expert clinical insight with real-world multimodality data to deliver meaningful results. By supporting every step of the workflow - ingest, store, view, quantify, and communicate - it provides a single platform to streamline clinical practice, research, and clinical trials.

Learn more

GIQuant

GIQuant is a software solution that turns subjective cine MRI sequences into a quantitative motility score in the small bowel.

By measuring how the bowel moves, GIQuant provides a validated objective score quantifying Crohn’s disease activity that can be tracked over time to support treatment decisions and clinical trials. GIQuant is CE marked (Class IIa) and FDA Cleared (Class II) for use in adults and children.

Learn more

Bridge

Bridge is a secure solution for capturing, storing, and sharing intestinal ultrasound (IUS) data. It connects directly to your ultrasound machine to capture scans, automatically de-identifies patient data, and links to Entrolytics for fast, compliant, and reliable workflows.

With built-in tools for transmission and storage, Bridge is ideal for clinical trials, routine practice, and education.

Learn more

vEUA

3D modelling technology for pelvic and perineal anatomy. Virtual Examination Under Anaesthetic (vEUA) enables clinicians to build an anatomically representative model of the sphincters, levator plate, and fistula tracts from MRI in under two minutes.

vEUA provides a clear, interactive visualisation of complex disease, making it easier for surgeons and radiologists to plan procedures, share findings with colleagues, and communicate with patients.

Learn more

Dynamic or 'cine' MRI offers a new and potentially powerful perspective on gastrointestinal function, especially in conditions like Crohn's where hypo-motility is related to disease activity. Objective assessment of this data with GIQuant could represent an important advance in how we quantify this in the clinic.

Professor Stuart Taylor - Consultant Radiologist, University College London

A fantastic, purpose built platform multi-rater scoring and mark-up of IBD imaging...

Jonathan Dillman - Pediatric Radiologist at Cincinnati Children's Hospital

Entrolytics is the only product I've found which excels at state-of-the-art IBD reporting, and multi-centre clinical research. It has the potential to help me deliver objective insights, as opposed to opinion alone, to my gastroenterologists and surgeons, without adding to the burden of my existing caseload. I am desperate to get it into use in my clinical workstream.

Dr Gauraang Bhatnagar - Employee of Motilent, and an Academic and Clinical Radiologist in Surrey, UK

STMM is a great tool as it provides rich information about the size and coordination of contractions in the stomach and colon without having to use invasive probes

Heather Fitzke - MSc PhD University College London

We enjoy using the Entrolytics platform for our interventional studies on small bowel motility using MRI. The analysis is straightforward with access to both simple and more advanced tools.

Esben Bolvig Mark - Postdoc researcher at Aalborg University Hospital, Denmark

We now have a lot of therapies for patients with Crohn's Disease. What is lacking is the tests to match the patient with the best treatment for them. GIQuant is a new tool for small bowel Crohn's based on MRI and I get a simple, objective score for a small bowel lesion helping me track treatment response. We're now about to start testing this technology across the NHS but non-invasive, objective and widely available tools like GIQuant are crucial to managing growing budgets and improving patient outcomes.

It's like a PACS but for Endoscopy, and on the web.

Dr Gordon Moran - University of Nottingham Associate Professor Consultant Gastroenterologist

I have used the Entrolytics platform in my research trials and it has been indispensable. Gone are the days of DICOM email attachments, measurements recorded in spreadsheets (without being able to trace them back to the original imaging), and incompatible PACS with missing features. Entrolytics is the future of auditable, high-quality research.

Dr Harbir Sidhu - Consultant Radiologist at UCLH